Literature DB >> 12384990

Emerging functions of p21-activated kinases in human cancer cells.

Rakesh Kumar1, Ratna K Vadlamudi.   

Abstract

The p21 activated kinases (Paks), an evolutionarily conserved family of serine/threonine kinases, are important for a variety of cellular functions including cell morphogenesis, motility, survival, mitosis, and angiogenesis. Paks are widely expressed in numerous tissues and are activated by growth factors and extracellular signals through GTPase-dependent and -independent mechanisms. Overexpression of Paks in epithelial cancer cells has been shown to increase migration potential, increase anchorage independent growth, and cause abnormalities in mitosis. Dysregulation of Paks has been reported in several human tumors and neurodegenerative diseases. A growing list of novel Pak interacting proteins has opened up exciting avenues of investigation by which to understand the functions of Paks in tumorigenesis. In this review, we will summarize the current knowledge of the Paks family with respect to emerging cellular functions and possible contributions to cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384990     DOI: 10.1002/jcp.10167

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  35 in total

1.  Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp.

Authors:  Monika Weisz Hubsman; Natalia Volinsky; Edward Manser; Deborah Yablonski; Ami Aronheim
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

2.  ROCK1 but not LIMK1 or PAK2 is a key regulator of apoptotic membrane blebbing and cell disassembly.

Authors:  Rochelle Tixeira; Thanh Kha Phan; Sarah Caruso; Bo Shi; Georgia K Atkin-Smith; Christina Nedeva; Jenny D Y Chow; Hamsa Puthalakath; Mark D Hulett; Marco J Herold; Ivan K H Poon
Journal:  Cell Death Differ       Date:  2019-05-01       Impact factor: 15.828

Review 3.  Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases.

Authors:  Rakesh Kumar; Aswathy Mary Paul; Ravikumar Amjesh; Bijesh George; M Radhakrishna Pillai
Journal:  Cancer Metastasis Rev       Date:  2020-08-21       Impact factor: 9.264

4.  Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.

Authors:  Samantha K McCarty; Motoyasu Saji; Xiaoli Zhang; David Jarjoura; Alfredo Fusco; Vasyl V Vasko; Matthew D Ringel
Journal:  Endocr Relat Cancer       Date:  2010-10-29       Impact factor: 5.678

5.  p21-activated kinase 1 regulates microtubule dynamics by phosphorylating tubulin cofactor B.

Authors:  Ratna K Vadlamudi; Christopher J Barnes; Suresh Rayala; Feng Li; Seetharaman Balasenthil; Stevan Marcus; Holly V Goodson; Aysegul A Sahin; Rakesh Kumar
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

6.  PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin.

Authors:  Jing Tao; Peter Oladimeji; Leah Rider; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2011-06-30

7.  Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.

Authors:  Melania Ester Mercado-Pimentel; Craig Miller; Daniela N Rolph; Edrick F Villalobos; Allison M Dunn; Prithvi M Mohan; Suzu Igarashi; Xiangdang Liu; Macken Yrun-Duffy; Neal K Patel; Cecilia M Read; Ross H Francis; Adelina Isabella Lane; Swaroop Murugesh; Abraham Jacob
Journal:  Otol Neurotol       Date:  2017-01       Impact factor: 2.311

8.  Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-alpha transactivation.

Authors:  A H Talukder; D-Q Li; B Manavathi; R Kumar
Journal:  Oncogene       Date:  2008-06-02       Impact factor: 9.867

9.  The integrin-binding protein Nischarin regulates cell migration by inhibiting PAK.

Authors:  Suresh K Alahari; Peter J Reddig; Rudy L Juliano
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

10.  Differential requirement for MEK Partner 1 in DU145 prostate cancer cell migration.

Authors:  Electa R Park; Ashok K Pullikuth; Evangeline M Bailey; Donald E Mercante; Andrew D Catling
Journal:  Cell Commun Signal       Date:  2009-11-23       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.